MEDIPOST Co., Ltd.
078160.KQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$316.2B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $316.20 Billion |
|---|---|
| Enterprise Value | $408.19 Billion |
| Earnings per Share | $-2193.4 |
| Beta | 0.43 |
| Outstanding Shares | 39,086,000 |
Return
| Return on Equity | -8.45% |
|---|---|
| Return on Assets | -4.13% |
| Return on Invested Capital | -22.17% |
Valuation & Multiples
| P/E Ratio | -11.49 |
|---|---|
| PEG | 4.92 |
| Price to Sales | 4.44 |
| Price to Book Ratio | 1.21 |
| Enterprise Value to Revenue | 5.45 |
| Enterprise Value to EBIT | -5.05 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.62 |
Revenue Sources
No data
Next Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$13.30 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MEDIPOST Co., Ltd.
322 employees
CEO: Won-Il Oh
Medipost Co., Ltd. is a biotechnology firm dedicated to the creation and manufacturing of stem cell-based products. Its diverse operations are categorized into several divisions: the Cord Blood Bank, which specializes in the collection a...